Geneos Wealth Management Inc. Verastem, Inc. Transaction History

Geneos Wealth Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$2.54 - $4.07 $762 - $1,221	-300 Closed	0 $0
Q2 2021 Jul 08, 2021	BUY	$2.57 - $4.85 $771 - $1,455	300 New	300 $1,000
Q4 2020 May 19, 2021	SELL	$1.15 - $2.4 $1,494 - $3,120	-1,300 Closed	0 $0
Q3 2018 Sep 07, 2021	BUY	$6.86 - $9.97 $6,860 - $9,970	1,000 Added 333.33%	1,300 $9,000
Q2 2018 Sep 07, 2021	BUY	$2.88 - $8.67 $864 - $2,601	300 New	300 $2,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.25B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.